James Robinson Specialities Profile
Key Indicators
- Authorised Capital ₹ 48.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 45.69 Cr
as on 15-11-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 21.24%
(FY 2023)
- Profit -331.10%
(FY 2023)
- Ebitda -76.58%
(FY 2023)
- Net Worth 504.79%
(FY 2023)
- Total Assets 110.71%
(FY 2023)
About James Robinson Specialities
The Corporate was formerly known as Vivimed Specialities Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 48.00 Cr and a paid-up capital of Rs 45.69 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at James Robinson Specialities Private Limited India is Bhavya Bhandawat as COMPANY SECRETARY. Sanketh Varalwar, Amit Aggarwal, and Vishal Mahapatruni serve as directors at the Company.
- CIN/LLPIN
U24304TG2018PTC127016
- Company No.
127016
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at James Robinson Specialities?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhavya Bhandawat | Company Secretary | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Mahapatruni  | Director | 20-Oct-2021 | Current |
Sanketh Varalwar  | Additional Director | Current | |
| Amit Aggarwal | Director | 20-Oct-2021 | Current |
Financial Performance of James Robinson Specialities.
James Robinson Specialities Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.24% increase. The company also saw a substantial fall in profitability, with a 331.1% decrease in profit. The company's net worth Soared by an impressive increase of 504.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of James Robinson Specialities?
In 2023, James Robinson Specialities had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vivimed Specialties (India) Private LimitedActive 5 years 11 monthsSanketh Varalwar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at James Robinson Specialities?
James Robinson Specialities has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of James Robinson Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped James Robinson Specialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
